# FDA Inspection 1329500 - Octapharma Plasma, Inc. - July 16, 2026

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/8a8fd7fa-7a7a-4f5e-87ca-d7f24a4c0591
Source feed: FDA_Inspections

> FDA Inspection 1329500 for Octapharma Plasma, Inc. on July 16, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1329500
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2026-07-16
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1181999 - 2022-10-14](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/8f0db41e-3f4f-46be-b0d5-ad795392d775)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/b9ffea61-980c-4bb4-ad7f-5a5f006dd7cd

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d